| Dr Timothy J Hunter, MD | |
|
1201 W Agency Rd, West Burlington, IA 52655-1645 | |
| (319) 754-4242 | |
| (319) 754-4079 |
| Full Name | Dr Timothy J Hunter |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 1201 W Agency Rd, West Burlington, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922003003 | NPI | - | NPPES |
| 080177069 | Other | IA | RAILROAD MEDICARE |
| 3159491 | Medicaid | IA | |
| 40525 | Other | IA | BLUECROSSBLUESHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 32117 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Great River Home Health Care | West burlington, IA | Home health agency |
| Great River Medical Center | West burlington, IA | Hospital |
| Oakview Nursing And Rehabilitation | Burlington, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeast Iowa Regional Medical Center Inc | 3870496417 | 189 |
News Archive
Transition Therapeutics Inc. announced that its wholly owned subsidiary, Transition Therapeutics Ireland Limited completed enrolment of the Phase 2 clinical study evaluating neuropsychiatric drug candidate ELND005 as a treatment for agitation and aggression in patients with mild, moderate and severe Alzheimer's disease ("AD").
New guidelines have been released redefining the parameters for high blood pressure so that the condition can be treated earlier.
An effective recovery has been observed in stroke patients and those with spinal cord injuries who have strong vitality and motivation to rehabilitate in clinical practice. However, it was not really clear how motivation facilitates functional recovery in brain science.
Abbott announced today that it has received CE Mark approval for the world's first drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease. Abbott's BVS device restores blood flow by opening a clogged vessel and providing support to the vessel until the device dissolves within approximately two years, leaving patients with a treated vessel free of a permanent metallic implant. Abbott's BVS device will be commercialized under the brand name ABSORB.
› Verified 3 days ago
| Entity Name | Southeast Iowa Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164433884 PECOS PAC ID: 3870496417 Enrollment ID: O20040130000139 |
News Archive
Transition Therapeutics Inc. announced that its wholly owned subsidiary, Transition Therapeutics Ireland Limited completed enrolment of the Phase 2 clinical study evaluating neuropsychiatric drug candidate ELND005 as a treatment for agitation and aggression in patients with mild, moderate and severe Alzheimer's disease ("AD").
New guidelines have been released redefining the parameters for high blood pressure so that the condition can be treated earlier.
An effective recovery has been observed in stroke patients and those with spinal cord injuries who have strong vitality and motivation to rehabilitate in clinical practice. However, it was not really clear how motivation facilitates functional recovery in brain science.
Abbott announced today that it has received CE Mark approval for the world's first drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease. Abbott's BVS device restores blood flow by opening a clogged vessel and providing support to the vessel until the device dissolves within approximately two years, leaving patients with a treated vessel free of a permanent metallic implant. Abbott's BVS device will be commercialized under the brand name ABSORB.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timothy J Hunter, MD 1201 W Agency Rd, West Burlington, IA 52655-1645 Ph: (319) 754-4242 | Dr Timothy J Hunter, MD 1201 W Agency Rd, West Burlington, IA 52655-1645 Ph: (319) 754-4242 |
News Archive
Transition Therapeutics Inc. announced that its wholly owned subsidiary, Transition Therapeutics Ireland Limited completed enrolment of the Phase 2 clinical study evaluating neuropsychiatric drug candidate ELND005 as a treatment for agitation and aggression in patients with mild, moderate and severe Alzheimer's disease ("AD").
New guidelines have been released redefining the parameters for high blood pressure so that the condition can be treated earlier.
An effective recovery has been observed in stroke patients and those with spinal cord injuries who have strong vitality and motivation to rehabilitate in clinical practice. However, it was not really clear how motivation facilitates functional recovery in brain science.
Abbott announced today that it has received CE Mark approval for the world's first drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease. Abbott's BVS device restores blood flow by opening a clogged vessel and providing support to the vessel until the device dissolves within approximately two years, leaving patients with a treated vessel free of a permanent metallic implant. Abbott's BVS device will be commercialized under the brand name ABSORB.
› Verified 3 days ago
Dr. Dennis George Miller I, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1706 W Agency Rd, West Burlington, IA 52655 Phone: 319-768-5858 Fax: 319-753-2301 | |
David W Carlson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 W Agency Rd, West Burlington, IA 52655 Phone: 319-754-4242 Fax: 319-754-4079 | |
Michael K Abouassaly, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 W Agency Rd, West Burlington, IA 52655 Phone: 319-754-4242 Fax: 319-754-4079 | |
William S Daft, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 W Agency Rd, West Burlington, IA 52655 Phone: 319-754-4242 Fax: 319-754-4079 | |
Dr. Anjali Katiyar Sobti, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 W Agency Rd, West Burlington, IA 52655 Phone: 319-754-4242 | |
Thomas C Boyd, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1201 W Agency Rd, West Burlington, IA 52655 Phone: 319-754-4242 Fax: 319-754-4709 | |
Jennifer Bagwell De La Rosa, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 W Agency Rd, West Burlington, IA 52655 Phone: 319-754-4242 Fax: 319-754-4079 |